NSC20116
NSC20116 is a uracil derivative that specifically targets the Set-and-Ring (SRA) domain of the oncogene UHRF1. NSC20116 binds to the 5-methylcytosine (5mC) recognition pocket of UHRF1 SRA domain, with a dissociation constant (Kd) of 362 nM. NSC20116 can be used for the study of cancer[1].
Product Specifications
CAS Number
644-37-1
UNSPSC
12352005
Target
Drug Derivative; E1/E2/E3 Enzyme
Related Pathways
Metabolic Enzyme/Protease; Others
Field of Research
Cancer
Smiles
O=NNC1=CNC(NC1=O)=O
Molecular Formula
C4H4N4O3
Molecular Weight
156.10
References & Citations
[1]Akrani I, et al. Discovery and Characterization of Uracil Derivatives Targeting the Set-and-Ring Domain of UHRF1. J Chem Inf Model. 2025 Sep 8;65 (17) :9274-9286.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
137764 100 Tests
CD5 (T-cell Surface Glycoprotein CD5, Lymphocyte Antigen T1/Leu-1, LEU1) (FITC) discontinued, see C2255-85Q
Sign In for Pricing
View Details 
